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. E\\'E R OPl l .'\NTAGONJ T , T HE IR ACT ION AND SE 
PAUL R. DtMKE, i\ l.D.• 
l-.. arly in the history of medicine, opium was found to be a reliable and potent 
agent for the relief of pain. Through purification morphine has become popular a, 
a potent and ,uperior analgesic agent. l\ lorphine and all of its derivatives are 
effective becau',e they elevate the puin threshold, produce sleep, alleviate fear and 
produce relaxation. Respiratory depression and not infrequently circulatory de~ 
press1on are not uncommon when these drugs are exhibited in an attempt to 
attain rna,imum therapeutic effect and are a most dangerous symptom of opiate 
intoxication. These deleterious effects have in many ins tances precl uded che1r 
u~e in geriacr1c, pediatric and obstetric patients. 
Demethylation of morphine, codeine and other related alkaloids diminishes their 
analgesic potency. In 1915 Pohl' by substitution of an ally! for a methyl group in 
codeine, produced a compound called 1 -allylnorcodeine that counteracted to some 
extent the respiratory dcpres\ant effect of morphine. i\lcC:twley, Hart and 
\ 1ari..h 2 in 1941 substituted an ally! for a methyl group in morphine. This com-
pound known a\ ~ -allylnormorphine was shown tO have marked stimulatory 
effecti.. on respiration and circulation in animals depressed by morphine. In 1943 
l nna1 reported its use in antagoni1ing the effects of morphine injec ted into mice. 
The data rernained in the literature as a pharmacological curiosity until 1952 when 
1·.ckenhoff, Elder and King• reported the use of N-allylnormorphine in the treat-
ment of morphine and demerol narcosis and overdose. 
" -illl) lnormorphine is stru rurally identica l with morphine except for the re-
placement of a methyl group. ( Fig. I) i\ leperidine is structurally different from 
morphine when the formula is ,Hitten on paper, and the relationship between the 
t\\O molecule.., i, obscure; but when t hree-dimensional models are constructed 
there 1, a clo..,e \lmilarity of pauern, so we can expect N-allylnormorphine to 
,rntagon11e meperidine. Recent clinical studies have shown N-all ylnormorphine 
to he etfecr1,·e agam"lt clepres..,ion produced hr dilaudid, metapon, methadon, 





utl ine diagrams of molecules o i morphine and nalo rph ine. 
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N-allylnormorphine is quite interesting. Injected intravenou.,ly into a normal 
unpremedicated individual, it acts as a respiratory and circulatory depressant. 
Evidence presented by Tenney et. al.Ii points ro the fact that N-allylnormorphine 
changes the threshold response of the respiratory center to carbon dioxide tension 
or pH. The sensitivity of the respiratory center is lowered by appro'ti1nately 
50 percent. 
\\'hen the drug is injected into man, prior to the administration of a large dose 
of morphine, it inhibits the respiratory and circulatory depressant actions of the 
opiate; injected into a patient narcotized from large doses of the opiate~, it causes 
a strong respiratory stimulation as well as a moderate circulatory sti mulation. 
In spite of the stimulatory actions following opiate depression N-allylnormorphine 
seems to do little to counteract the sedation and analgesia produced by the opiates. 
Injection of N-allylnormorphine into a subject deeply narcotized by morphine or 
any of its derivatives produces a dramatic effect as far as respiratory ~timulation 
1s concerned. The respiratory stim ulation when 5 mgm. of the drug is exhibited 
intravenously in a patient narcotized with 60 mgm. of intravenous morphine is 
.., triking. The deep slow respirations that characterize opiate poisoning abruptly 
change after the antagonist is exhibited . In 15 or 20 seconds respiratory rate is 
increased 3-~ fold with regular less deep breathing. The change is not gradual 
as one sees after picrotoxin antagonism of barbiturate intoxication, nor is it an 
intense st imulation such as that seen with nikethamide or metrazol. Intense 
, timulntion and then the gradu:11 decline in respirator)' rate and minute volume 
1s not a characteristic of the new antagonist. 
The effect of the antagonism on the circulation of the narcotized patient is 
nor dramatic. If the blood pressure is depressed, it returns toward normal levels. 
If the pressure is normal the drug causes no marked change. The pulst" rare is uni-
formly slowed. 
The site of action of N-allylnormorphine has not been defined, but it is probably 
central. It may ac t in a competitive fashion with the opiates for certain receptor~ 
on cells of the central nervous system. It is possible for the drug to either oc-
cupy rhe receptor and block the action of the opiate, or it may displace the opiate. 
This is probably a nonspecific action because rhe sedative effect of the opiate is 
not blocked or completely displaced. 
Another drug capable of the same effecrs against some of the opiate~ is leval-
lorphan tart rate (3-hydroxy-n-allyl-morphinan). It bears a relationship ro clrom-
oran similar to that ofN-allylnormorphine to morphine. It is an effective antagon-
ist against respiratory depression produced by dromoran, nisentil, morphine, and 
demerol. Here then, we have two drugs which can be used intravenously to 
combat ro'tic effects of narcotics. 
Some anesthetists have been usi ng these drug~ prophylaccically in an attempt tO 
eliminate the respiratory depressant and hypotensive effect \ that intravenous 
opia tes possess. Obstetricians arc using rhe drugs prior to delivery of an infonr 
from a mother who is unduly depressed by opiates. 1 The respiratory <lepres~ion 
in the newborn due to placental transfer of opiates is prevented by the antagonists. 
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The drug may abo be given in 2 mgm. doses directl)r into the infant's umbilical 
vcan if the depression of the newborn is thought t0 be due to opiates. ed this 
v.ay rhe analcptic effect is quite dramatic. 
It is important to remember that these drugs have no effect on depression of 
circulation or respiration caused by the barbiturates or any of the anesthetic 
agents. They are specific antagonists of opiates. 1 .allylnormorphine or leval. 
!orphan in persons not under the influence of narcotics produces lethargy, mild 
drowsincsi,, vivid daydreams, and dysphoria varying in intensity from vague 
anxiety to acute panic. All subjects complained of inability to repress such day-
dreami,. 
Of course, it goes without saying that these two drugs are life saving in the 
pre. ence of severe opiate overdose, be it self-induced or accidental. The drugs are 
specific and are u~ed in a 10 mgm. dose intravenously after the usual clear airway 
and adequate oxygenation of the patient is obtained. Repeated injections of the 
drug every 4-5 minutes, until 60 mgm. or more have been given, may be required 
to effect a . timulation of respiration and circulation in a severely poisoned in-
dindual. 
It would~ interesting to know what specific structural unit of N-allylnormor-
phine ;.m<l le\"allorphan causes the antagonism of the opia tes. If such a unit 1s 
found the chemists might be able to synthesize drugs which could have the same 
effect of antagonizing the respiratory depressant effects of barbiturates or cyclo-
propane. 
Progre,s i\ being made in this direction. A wide number of drugs have been re-
ported to have analeptic properties against rhe opiares. All of these analepric 
drug, have either a muscarine like action or are anti-choline esterase drugs. -\ 
common chemical link in all of these drugs is a 2-4 diamino 5 phenyl thiazole. 
\\"hen drug "ith this linkage were rried against barbiturate intoxicated dog-. 
the,- \\ere rou ed. ..\ report of successful trials in animals and in 20 cases of bar-
hiturate po1"i0ning in man of a new drug incorporating the 2-4 diamino 5 phenyl 
chia,ole linkage ha, recent!)' been made. This may be the linkage which is common 
ro analcptic of rhis type. It will be interesting to see if the speci fic structural 
CI 3""'-c/ I 2 C ~ B 
C 2 ~ ~CH 2-----'C 0/ 
F,g. 2-bh ~! ETHYL ETHYL GL TARl~IIDE 
(, P 13) 
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unit can be isolated and u,;;ed successfully. The barbiturate antagonist increased 
respiration and as the dose was increased produced wakening. If the drug is used 
in normal subjects it produces convulsions which can be controlled with barbi-
turates. The new drug (Fig. 2) is designated NP 13. Chemically it is bb methyl 
ethyl glutarimide and is quite specific against barbiturates. 
The opiate antagonists are proving their usefulness everyday. Barbiturate 
antagonists with as much specificity as N-allylnormorphine would be a great ad-
vance in treatment of barbiturate toxicity. 
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